| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Net revenue | 61,250 | 61,082 | 52,411 | 54,573 |
| Cost of revenue | 15,976 | 17,063 | 14,149 | 14,513 |
| Gross profit | 45,274 | 44,019 | 38,262 | 40,060 |
| Sales and marketing | 18,652 | 19,103 | 16,572 | 16,750 |
| General and administrative | 29,155 | 30,443 | 30,280 | 26,299 |
| Impairment of indefinitely-lived assets | 2,268 | - | - | - |
| Restructuring | 2,294 | 2,971 | 40 | - |
| Research and development | 2,333 | 2,159 | 2,351 | 2,577 |
| Total operating expenses | 54,702 | 54,676 | 49,243 | 45,626 |
| Operating loss | -9,428 | -10,657 | -10,981 | -5,566 |
| Interest expense, net | 1,822 | 1,116 | 1,126 | 404 |
| Loss on extinguishment of debt | 0 | - | - | -3,230 |
| Other expense (income) | -648 | 4,709 | 1,644 | 63 |
| Total other expense (income), net | -2,470 | 3,593 | 518 | -3,571 |
| Net loss before income taxes | -11,898 | -7,064 | -10,463 | -9,137 |
| Income tax (benefit) charge | -125 | 49 | 196 | -1,218 |
| Net loss | -11,773 | -7,113 | -10,659 | -7,919 |
| Net loss per share - basic (in dollars per share) | -0.5 | -0.3 | -0.46 | -0.34 |
| Net loss per share - diluted (in dollars per share) | -0.5 | -0.3 | -0.46 | -0.34 |
| Weighted average shares outstanding - basic (in shares) | 23,565,779 | 23,460,144 | 23,230,871 | 23,171,249 |
| Weighted average shares outstanding - diluted (in shares) | 23,565,779 | 23,460,144 | 23,230,871 | 23,171,249 |
ORTHOPEDIATRICS CORP (KIDS)
ORTHOPEDIATRICS CORP (KIDS)